Literature DB >> 20409980

O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.

Victor V Lima1, Christiné S Rigsby, David M Hardy, R Clinton Webb, Rita C Tostes.   

Abstract

O-Linked attachment of beta-N-acetyl-glucosamine (O-GlcNAc) on serine and threonine residues of nuclear and cytoplasmic proteins is a highly dynamic posttranslational modification that plays a key role in signal transduction pathways. Preliminary data show that O-GlcNAcylation may represent a key regulatory mechanism in the vasculature, modulating contractile and relaxant responses. Proteins with an important role in vascular function, such as endothelial nitric oxide synthase, sarcoplasmic reticulum Ca(2+)-ATPase, protein kinase C, mitogen-activated protein kinases, and proteins involved in cytoskeleton regulation and microtubule assembly are targets for O-GlcNAcylation, indicating that this posttranslational modification may play an important role in vascular reactivity. Here, we will focus on a few specific pathways that contribute to vascular function and cardiovascular disease-associated vascular dysfunction, and the implications of their modification by O-GlcNAc. New chemical tools have been developed to detect and study O-GlcNAcylation, including inhibitors of O-GlcNAc enzymes, chemoenzymatic tagging methods, and quantitative proteomics strategies; these will also be briefly addressed. An exciting challenge in the future will be to better understand the cellular dynamics of this posttranslational modification, as well as the signaling pathways and mechanisms by which O-GlcNAc is regulated on specific proteins in the vasculature in health and disease.

Entities:  

Year:  2009        PMID: 20409980      PMCID: PMC3022480          DOI: 10.1016/j.jash.2009.09.004

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  130 in total

1.  O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.

Authors:  Keith Vosseller; Jonathan C Trinidad; Robert J Chalkley; Christian G Specht; Agnes Thalhammer; Aenoch J Lynn; June O Snedecor; Shenheng Guan; Katalin F Medzihradszky; David A Maltby; Ralf Schoepfer; Alma L Burlingame
Journal:  Mol Cell Proteomics       Date:  2006-02-01       Impact factor: 5.911

2.  Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli - VASOACTIVE PEPTIDE SYMPOSIUM.

Authors:  Victor V Lima; Fernanda R C Giachini; Fernando S Carneiro; Zidonia N Carneiro; Zuleica B Fortes; Maria Helena C Carvalho; R Clinton Webb; Rita C Tostes
Journal:  J Am Soc Hypertens       Date:  2008 Nov-Dec

3.  Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

Review 4.  Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension.

Authors:  Daisy A Salamanca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2005-09-01       Impact factor: 5.858

5.  Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.

Authors:  Michele E Forsythe; Dona C Love; Brooke D Lazarus; Eun Ju Kim; William A Prinz; Gilbert Ashwell; Michael W Krause; John A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

6.  Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.

Authors:  A Virkamäki; M C Daniels; S Hämäläinen; T Utriainen; D McClain; H Yki-Järvinen
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

7.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.

Authors:  Keith Vosseller; Lance Wells; M Daniel Lane; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

8.  Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils.

Authors:  Zachary T Kneass; Richard B Marchase
Journal:  J Biol Chem       Date:  2005-02-09       Impact factor: 5.157

9.  Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.

Authors:  Natasha Elizabeth Zachara; Win Den Cheung; Gerald Warren Hart
Journal:  Methods Mol Biol       Date:  2004

10.  Identification of new O-GlcNAc modified proteins using a click-chemistry-based tagging.

Authors:  Caroline Gurcel; Anne-Sophie Vercoutter-Edouart; Catherine Fonbonne; Marlène Mortuaire; Arnaud Salvador; Jean-Claude Michalski; Jérôme Lemoine
Journal:  Anal Bioanal Chem       Date:  2008-03-28       Impact factor: 4.142

View more
  17 in total

1.  O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway.

Authors:  Victor V Lima; Fernanda R Giachini; Fernando S Carneiro; Maria Helena C Carvalho; Zuleica B Fortes; R Clinton Webb; Rita C Tostes
Journal:  Cardiovasc Res       Date:  2010-10-26       Impact factor: 10.787

2.  High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity?

Authors:  Victor V Lima; Fernanda R Giachini; Takayuki Matsumoto; Weiguo Li; Alecsander F M Bressan; Dhruv Chawla; R Clinton Webb; Adviye Ergul; Rita C Tostes
Journal:  Clin Sci (Lond)       Date:  2016-02-29       Impact factor: 6.124

3.  Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation.

Authors:  Timea Beleznai; Zsolt Bagi
Journal:  Vascul Pharmacol       Date:  2011-12-03       Impact factor: 5.773

Review 4.  O-GlcNAc signaling in the cardiovascular system.

Authors:  Gladys A Ngoh; Heberty T Facundo; Ayesha Zafir; Steven P Jones
Journal:  Circ Res       Date:  2010-07-23       Impact factor: 17.367

Review 5.  Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.

Authors:  Victor M Darley-Usmar; Lauren E Ball; John C Chatham
Journal:  J Mol Cell Cardiol       Date:  2011-08-22       Impact factor: 5.000

Review 6.  O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.

Authors:  Victor V Lima; Fernanda R Giachini; David M Hardy; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-10       Impact factor: 3.619

7.  dbOGAP - an integrated bioinformatics resource for protein O-GlcNAcylation.

Authors:  Jinlian Wang; Manabu Torii; Hongfang Liu; Gerald W Hart; Zhang-Zhi Hu
Journal:  BMC Bioinformatics       Date:  2011-04-06       Impact factor: 3.169

Review 8.  O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?

Authors:  Victor V Lima; Kathryn Spitler; Hyehun Choi; R Clinton Webb; Rita C Tostes
Journal:  Clin Sci (Lond)       Date:  2012-10       Impact factor: 6.124

9.  Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.

Authors:  Stefany B A Cau; Fernando S Carneiro; Rita C Tostes
Journal:  Front Physiol       Date:  2012-06-25       Impact factor: 4.566

10.  Short-term glucosamine infusion increases islet blood flow in anesthetized rats.

Authors:  Xiang Gao; Leif Jansson; A Erik G Persson; Monica Sandberg
Journal:  Islets       Date:  2013-11-25       Impact factor: 2.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.